**Molecular Mechanism and Rationale**
The molecular foundation of microglial replacement and ontogeny shift centers on the chemokine receptor CCR2 and its cognate ligand CCL2 (monocyte chemoattractant protein-1, MCP-1). Under homeostatic conditions, yolk sac-derived microglia populate the central nervous system during embryonic development and self-renew throughout life without significant contribution from circulating monocytes. However, perinatal immune activation fundamentally disrupts this
**Molecular Mechanism and Rationale**
The proposed mechanism centers on liver disease-induced breakdown of blood-brain barrier (BBB) integrity through matrix metalloproteinase-9 (MMP-9) upregulation, facilitating CCR2+ peripheral monocyte infiltration into brain parenchyma where they adopt altered phenotypes that mimic microglial dysfunction. In healthy conditions, the BBB maintains strict control over immune cell trafficking through tight junction proteins including claudin-5, occludin, and zo
Convergent vs Divergent Predictions
This summary checks where the selected hypotheses point toward the same target or mechanism, and where they pull in opposite directions.
CCR2Neuroinflammation
Convergent signals
CCR2 recurs across 2 selected hypotheses with aligned directionality in neuroinflammation.
Divergent signals
No direct polarity conflicts detected among the selected hypotheses.
# Critical Evaluation of IBA1 Low/Negative Microglia Hypotheses
I'll systematically evaluate each hypothesis against your skeptic's framework, identifying mechanistic weaknesses, missing controls, al...
Domain Expert
# Feasibility Assessment: IBA1 Low/Negative Microglia in Liver Disease
## Prefatory Notes on Surviving Hypotheses
From the skeptic's prior evaluation (partial), the surviving candidates with suffici...